Advances in genetic prenatal diagnosis and screening

Current Opinion in Pediatrics

Volumn 26, Issue 6, 2014, Pages 634-638

  Hardisty, Emily E ^a   Vora, Neeta L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosomal microarray analysis; Noninvasive prenatal testing; Prenatal diagnosis

Indexed keywords

ANEUPLOIDY; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DOWN SYNDROME; FETUS KARYOTYPING; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MATERNAL AGE; MATERNAL SERUM; MICROARRAY ANALYSIS; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SPINAL DYSRAPHISM; TRISOMY 13; TRISOMY 18; FEMALE; MASS SCREENING; PREGNANCY; PROCEDURES;

ANEUPLOIDY; FEMALE; HUMANS; MASS SCREENING; MICROARRAY ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84927691056     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000145     Document Type: Review

References (22)

1. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013; 15: 565-574.
2. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-764.
3. The American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013; 122: 1374-1377.
4. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175-2184.
5. Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and metaanalysis. Ultrasound Obstet Gynecol 2013; 41: 610-620.
6. Brady PD, Delle Chiaie B, Christenhusz G, et al. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 2014; 16: 469-476.
7. Harper LM, Sutton ALM, Longman RE, Odibo AO. An economic analysis of prenatal cytogenetic technologies for sonographically detected fetal anomalies. Am J Med Genet A 2014; 164A: 1192-1197.
8. Gil MM, Akolekar R, Quezada MS, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 2014; 35: 156-173.
9. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012; 32: 730-734.
10. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012; 14: 296-305.
11. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119: 890-901.
12. Nicolaides KH, Syngelaki A, del Mar Gil M, et al. Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood. Fetal Diagn Ther 2014; 35: 212-217.
13. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207: 374.e1-374.e6.
14. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
15. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808.
16. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013; 33: 609-611.
17. Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014; 60: 251-259.
18. Mao J, Wang T, Wang BJ, et al. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant noninvasive prenatal test result in a trisomy 18 pregnancy. Clin Chim Acta 2014; 433: 190-193.
19. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012; 58: 1148-1151.
20. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013; 92: 167-176.
21. Rabinowitz M, Savage M, Pettersen B, et al. Noninvasive cell-free DNA-based prenatal detection of microdeletions using single nucleotide polymorphismtargeted sequencing. Obstet Gynecol 2014; 123: 167S.
22. Vora NL, O'brien BM. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014; 123: 1097-1099.